CAPRICOR THERAPEUTICS, INC. Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization
CAPRICOR THERAPEUTICS, INC. (CAPR) had Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization of $1.60 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets › Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization
us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedBeforeAccumulatedAmortization · last filed 2026-08-14
- 2026-06-30: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $1.60M.
- 2026-03-31: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $1.50M.
- 2025-12-31: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $1.10M.
- 2025-09-30: Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization $845.76K.
| Period end | Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization |
|---|---|
| 2026-06-30 | $1.60M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.10M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $845.76K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $306.78K 10-Q · filed 2025-08-11 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |